Pre-surgery serum samples from biopsy-confirmed prostate cancer patients (n = 131), BPH/prostatitis patients (n = 121) and healthy donors (n = 124), which were independent of the samples used in the epitope discovery phase, were subjected to determining total PSA and autoAb against the 6 defined PCAA epitopes. The gene discussed is KLK3; the disease is medical procedure.